Forbes -
21 Apr 2014 19:19
In trading on Monday, the SPDR S&P Pharmaceuticals ETF (XPH) is outperforming other ETFs, up about 1.3% on the day. Components of that ETF showing particular strength include shares of Impax Laboratories (IPXL), up about 4.4% and shares of Repros Therapeutics (RPRX), up about 4.3% on the day.
Share this Article
Comment on this Article
Please to comment